Clinical trial
The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
NCT02364453 is registered in ClinicalTrials.gov with Song Guo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
- Lead sponsor
- Song Guo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- April 30, 2016
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.